BACKGROUND: HIV/AIDS disproportionately affects minority groups in the United States, especially in the rural southeastern states. Poverty and lack of access to HIV care, including clinical trials, are prevalent in these areas and contribute to HIV stigma. This is the first study to develop a conceptual model exploring the relationship between HIV stigma and the implementation of HIV clinical trials in rural contexts to help improve participation in those trials. METHODS: We conducted focus groups with HIV service providers and community leaders, and individual interviews with people living with HIV/AIDS in six counties in rural North Carolina. Themes related to stigma were elicited. We classified the themes into theoretical constructs and developed a conceptual model. RESULTS: HIV stigma themes were classified under the existing theoretical constructs of perceived, experienced, vicarious, and felt normative stigma. Two additional constructs emerged: causes of HIV stigma (e.g., low HIV knowledge and denial in the community) and consequences of HIV stigma (e.g., confidentiality concerns in clinical trials). The conceptual model illustrates that the causes of HIV stigma can give rise to perceived, experienced, and vicarious HIV stigma, and these types of stigma could lead to the consequences of HIV stigma that include felt normative stigma. LIMITATIONS: Understanding HIV stigma in rural counties of North Carolina may not be generalizeable to other rural US southeastern states. CONCLUSION: The conceptual model emphasizes that HIV stigma--in its many forms--is a critical barrier to HIV clinical trial implementation in rural North Carolina.
BACKGROUND: HIV/AIDS disproportionately affects minority groups in the United States, especially in the rural southeastern states. Poverty and lack of access to HIV care, including clinical trials, are prevalent in these areas and contribute to HIV stigma. This is the first study to develop a conceptual model exploring the relationship between HIV stigma and the implementation of HIV clinical trials in rural contexts to help improve participation in those trials. METHODS: We conducted focus groups with HIV service providers and community leaders, and individual interviews with people living with HIV/AIDS in six counties in rural North Carolina. Themes related to stigma were elicited. We classified the themes into theoretical constructs and developed a conceptual model. RESULTS:HIV stigma themes were classified under the existing theoretical constructs of perceived, experienced, vicarious, and felt normative stigma. Two additional constructs emerged: causes of HIV stigma (e.g., low HIV knowledge and denial in the community) and consequences of HIV stigma (e.g., confidentiality concerns in clinical trials). The conceptual model illustrates that the causes of HIV stigma can give rise to perceived, experienced, and vicarious HIV stigma, and these types of stigma could lead to the consequences of HIV stigma that include felt normative stigma. LIMITATIONS: Understanding HIV stigma in rural counties of North Carolina may not be generalizeable to other rural US southeastern states. CONCLUSION: The conceptual model emphasizes that HIV stigma--in its many forms--is a critical barrier to HIV clinical trial implementation in rural North Carolina.
Authors: Janni J Kinsler; Mitchell D Wong; Jennifer N Sayles; Cynthia Davis; William E Cunningham Journal: AIDS Patient Care STDS Date: 2007-08 Impact factor: 5.078
Authors: William D King; Donna Defreitas; Kimberly Smith; Janet Andersen; Lisa Patton Perry; Toyin Adeyemi; Jennifer Mitty; Jan Fritsche; Carrie Jeffries; Melvin Littles; Margaret Fischl; Gregory Pavlov; Donna Mildvan Journal: AIDS Patient Care STDS Date: 2007-08 Impact factor: 5.078
Authors: Becky L Genberg; Zdenek Hlavka; Kelika A Konda; Suzanne Maman; Suwat Chariyalertsak; Alfred Chingono; Jessie Mbwambo; Precious Modiba; Heidi Van Rooyen; David D Celentano Journal: Soc Sci Med Date: 2009-05-07 Impact factor: 4.634
Authors: Chuen-Yen Lau; Edith M Swann; Sagri Singh; Zuhayr Kafaar; Helen I Meissner; James P Stansbury Journal: Vaccine Date: 2011-08-05 Impact factor: 3.641
Authors: Julie Barroso; Michael V Relf; Megan Scull Williams; Joyell Arscott; Elizabeth D Moore; Courtney Caiola; Susan G Silva Journal: AIDS Patient Care STDS Date: 2014-08-01 Impact factor: 5.078
Authors: Jannette Y Berkley-Patton; Erin Moore; Marcie Berman; Stephen D Simon; Carole Bowe Thompson; Thomas Schleicher; Starlyn M Hawes Journal: J Int AIDS Soc Date: 2013-11-13 Impact factor: 5.396
Authors: Zorica Terzic-Supic; Milena Santric-Milicevic; Momcilo Mirkovic; Svetlana Karic; Ivan Soldatovic Journal: BMC Int Health Hum Rights Date: 2015-11-17